Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €12.00 EUR
Change Today 0.00 / 0.00%
Volume 1.4K
As of 11:02 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

median technologies (ALMDT) Snapshot

Open
€11.99
Previous Close
€12.00
Day High
€12.00
Day Low
€11.99
52 Week High
07/16/15 - €12.00
52 Week Low
03/3/15 - €7.30
Market Cap
118.9M
Average Volume 10 Days
2.5K
EPS TTM
€-0.76
Shares Outstanding
9.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDIAN TECHNOLOGIES (ALMDT)

Related News

No related news articles were found.

median technologies (ALMDT) Related Businessweek News

No Related Businessweek News Found

median technologies (ALMDT) Details

MEDIAN Technologies S.A. provides medical imaging products and integrated services for diagnosing and monitoring cancer patients in routine clinical practice and clinical drug development. The company’s products include MEDIAN CTIS, a change paradigm for image interpretation and management; and lesion management solutions for diagnosing and treating cancer patients. It also offers lung cancer screening imaging, clinical trial imaging, and managed services, as well as companion and monitoring tests. MEDIAN Technologies S.A. has strategic partnership with Canon, Inc.; Kuwait Life Science Company; and Quintiles. The company was founded in 2002 and is based in Valbonne, France.

47 Employees
Last Reported Date: 04/15/15
Founded in 2002

median technologies (ALMDT) Top Compensated Officers

Co-Founder, Chairman, Chief Executive Officer...
Total Annual Compensation: €233.0K
Co-Founder, Executive Vice President and Dire...
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

median technologies (ALMDT) Key Developments

MEDIAN Technologies Announces New Awarded Projects and a New Contract for Image Interpretation and Management in Clinical Trials Totaling €5.31 Million

MEDIAN Technologies announced that it has been selected to provide imaging solutions and services for six new clinical studies in oncology. These six new projects total approximately €5.31 million. Awarded projects: a phase III study (non-small cell lung cancer - NSCLC) for a total of €1.8 million; a phase III study (glioblastoma) for a total of €1.49 million; a phase III study (metastatic gastric adenocarcinoma) for a total of €846,000; a phase Ib/II study (metastatic breast cancer) for a total of €378,000; and a phase II study (myelofibrosis) for a total of €259,000. Contract: a phase Ib/II study (kidney cancer) for a total of €532,000.

MEDIAN Technologies S.A. Presents at French Life Science Days conference, Jun-17-2015

MEDIAN Technologies S.A. Presents at French Life Science Days conference, Jun-17-2015 . Venue: W Hotel, 541 Lexington Avenue, New York, NY 10022, United States.

MEDIAN Technologies S.A. Reports Audited Earnings Results for the Full Year of 2014

MEDIAN Technologies S.A. reported audited earnings results for the full year of 2014. For the period, the company reported total turnover of EUR 1,518,000 compared to EUR 1,203,000 a year ago. Total operating income was EUR 3,282,000 compared to EUR 1,450,000 a year ago. Operating loss was EUR 5,725,000 compared to EUR 4,589,000 a year ago. Net loss was EUR 4,844,000 compared to EUR 4,348,000 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALMDT:FP €12.00 EUR 0.00

ALMDT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ALMDT.
View Industry Companies
 

Industry Analysis

ALMDT

Industry Average

Valuation ALMDT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 59.3x
Price/Book 7.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 60.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIAN TECHNOLOGIES, please visit www.mediantechnologies.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.